克隆-话题@MedSci

#克隆#

209篇内容 | 3874人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1660108, encodeId=b6831660108b3, content=<a href='/topic/show?id=8d0d28912db' target=_blank style='color:#2F92EE;'>#克隆#</a>, objectTitle=Stem Cell Reports：无需克隆的基因编辑技术，可能会改变医学治疗的未来, objectType=article, longId=58534, objectId=ea3858534e8, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=ea3858534e8, replyNumber=0, likeNumber=55, createdTime=2015-11-22, rootId=0, userName=aids221, userId=596825099872, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=ea3858534e8, moduleTitle=Stem Cell Reports：无需克隆的基因编辑技术，可能会改变医学治疗的未来, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=ea3858534e8)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1660105, encodeId=4de716601056f, content=<a href='/topic/show?id=8d0d28912db' target=_blank style='color:#2F92EE;'>#克隆#</a>, objectTitle=Oncotarget：抗β2微球蛋白单克隆抗体能改善硼替佐米的耐药性, objectType=article, longId=50446, objectId=91065044631, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=91065044631, replyNumber=0, likeNumber=77, createdTime=2016-02-14, rootId=0, userName=aids221, userId=596825099872, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=91065044631, moduleTitle=Oncotarget：抗β2微球蛋白单克隆抗体能改善硼替佐米的耐药性, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=91065044631)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1660103, encodeId=474216601031d, content=<a href='/topic/show?id=8d0d28912db' target=_blank style='color:#2F92EE;'>#克隆#</a>, objectTitle=Cancer Cell：新型单克隆抗体药物或可有效克服白血病的耐药性, objectType=article, longId=49528, objectId=ffc44952814, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=ffc44952814, replyNumber=0, likeNumber=52, createdTime=2016-02-23, rootId=0, userName=aids221, userId=596825099872, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=ffc44952814, moduleTitle=Cancer Cell：新型单克隆抗体药物或可有效克服白血病的耐药性, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=ffc44952814)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1660106, encodeId=a12916601066a, content=<a href='/topic/show?id=8d0d28912db' target=_blank style='color:#2F92EE;'>#克隆#</a>, objectTitle=J Clin Oncol：人体单克隆抗体新药的试验设计需要改进, objectType=article, longId=51457, objectId=082d5145e4b, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=082d5145e4b, replyNumber=0, likeNumber=71, createdTime=2015-11-10, rootId=0, userName=aids221, userId=596825099872, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=082d5145e4b, moduleTitle=J Clin Oncol：人体单克隆抗体新药的试验设计需要改进, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=082d5145e4b)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1660101, encodeId=36d4166010106, content=<a href='/topic/show?id=8d0d28912db' target=_blank style='color:#2F92EE;'>#克隆#</a>, objectTitle=Nature：单克隆抗体Tildrakizumab对牛皮癣可能有效, objectType=article, longId=48108, objectId=9f4d48108fc, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=9f4d48108fc, replyNumber=0, likeNumber=81, createdTime=2016-01-03, rootId=0, userName=aids221, userId=596825099872, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=9f4d48108fc, moduleTitle=Nature：单克隆抗体Tildrakizumab对牛皮癣可能有效, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=9f4d48108fc)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1660102, encodeId=0c40166010231, content=<a href='/topic/show?id=8d0d28912db' target=_blank style='color:#2F92EE;'>#克隆#</a>, objectTitle=Cell Res：生殖细胞克隆新技术, objectType=article, longId=48779, objectId=e6c348e79f4, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=e6c348e79f4, replyNumber=0, likeNumber=83, createdTime=2015-04-28, rootId=0, userName=aids221, userId=596825099872, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=e6c348e79f4, moduleTitle=Cell Res：生殖细胞克隆新技术, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=e6c348e79f4)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1660100, encodeId=6477166010085, content=<a href='/topic/show?id=8d0d28912db' target=_blank style='color:#2F92EE;'>#克隆#</a>, objectTitle=新一代单克隆抗体类生物制药的特征, objectType=article, longId=36577, objectId=277d365e7c1, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=277d365e7c1, replyNumber=0, likeNumber=0, createdTime=2015-04-26, rootId=0, userName=aids221, userId=596825099872, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=277d365e7c1, moduleTitle=新一代单克隆抗体类生物制药的特征, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=277d365e7c1)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1660097, encodeId=1520166009e05, content=<a href='/topic/show?id=8d0d28912db' target=_blank style='color:#2F92EE;'>#克隆#</a>, objectTitle=刘梅林：PCSK9单克隆抗体“不负众望”, objectType=article, longId=32767, objectId=75e332e67bb, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=75e332e67bb, replyNumber=0, likeNumber=80, createdTime=2014-10-22, rootId=0, userName=aids221, userId=596825099872, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=75e332e67bb, moduleTitle=刘梅林：PCSK9单克隆抗体“不负众望”, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=75e332e67bb)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1660089, encodeId=8eb816600896c, content=<a href='/topic/show?id=8d0d28912db' target=_blank style='color:#2F92EE;'>#克隆#</a>, objectTitle=“克隆野山羊计划”再次萌动引发热议, objectType=article, longId=28102, objectId=030f28102b0, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=030f28102b0, replyNumber=0, likeNumber=84, createdTime=2014-09-20, rootId=0, userName=aids221, userId=596825099872, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=030f28102b0, moduleTitle=“克隆野山羊计划”再次萌动引发热议, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=030f28102b0)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1660099, encodeId=2aac166009942, content=<a href='/topic/show?id=8d0d28912db' target=_blank style='color:#2F92EE;'>#克隆#</a>, objectTitle=复宏汉霖获得单克隆抗体药物临床批件, objectType=article, longId=32937, objectId=8e9b3293eeb, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=8e9b3293eeb, replyNumber=0, likeNumber=65, createdTime=2014-11-28, rootId=0, userName=aids221, userId=596825099872, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=8e9b3293eeb, moduleTitle=复宏汉霖获得单克隆抗体药物临床批件, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=8e9b3293eeb)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1660091, encodeId=6df71660091c9, content=<a href='/topic/show?id=8d0d28912db' target=_blank style='color:#2F92EE;'>#克隆#</a>, objectTitle=BioTechniques：2014年生物新技术：下一代测序、RCR/克隆、蛋白分析、细胞分析, objectType=article, longId=28709, objectId=fc2e28e0952, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=fc2e28e0952, replyNumber=0, likeNumber=97, createdTime=2014-05-04, rootId=0, userName=aids221, userId=596825099872, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=fc2e28e0952, moduleTitle=BioTechniques：2014年生物新技术：下一代测序、RCR/克隆、蛋白分析、细胞分析, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=fc2e28e0952)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1660093, encodeId=48c316600935f, content=<a href='/topic/show?id=8d0d28912db' target=_blank style='color:#2F92EE;'>#克隆#</a>, objectTitle=Sciecne：2013年突破--人体胚胎克隆终获成功咖啡因助力, objectType=article, longId=29294, objectId=23da2929412, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=23da2929412, replyNumber=0, likeNumber=77, createdTime=2014-11-07, rootId=0, userName=hb2008ye, userId=4c37265, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=23da2929412, moduleTitle=Sciecne：2013年突破--人体胚胎克隆终获成功咖啡因助力, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=23da2929412)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1660096, encodeId=60a616600969e, content=<a href='/topic/show?id=8d0d28912db' target=_blank style='color:#2F92EE;'>#克隆#</a>, objectTitle=“科幻变现实”中国克隆工厂惊人, objectType=article, longId=29642, objectId=39bf2964295, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=39bf2964295, replyNumber=0, likeNumber=81, createdTime=2014-01-24, rootId=0, userName=aids221, userId=596825099872, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=39bf2964295, moduleTitle=“科幻变现实”中国克隆工厂惊人, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=39bf2964295)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1660090, encodeId=3300166009023, content=<a href='/topic/show?id=8d0d28912db' target=_blank style='color:#2F92EE;'>#克隆#</a>, objectTitle=Science ：《科学》评年度医学成果克隆技术竟需咖啡帮助, objectType=article, longId=28517, objectId=1a2f2851ea7, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=1a2f2851ea7, replyNumber=0, likeNumber=0, createdTime=2014-04-05, rootId=0, userName=aids221, userId=596825099872, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=1a2f2851ea7, moduleTitle=Science ：《科学》评年度医学成果克隆技术竟需咖啡帮助, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=1a2f2851ea7)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1660088, encodeId=4a691660088b4, content=<a href='/topic/show?id=8d0d28912db' target=_blank style='color:#2F92EE;'>#克隆#</a>, objectTitle=J Virol：上海巴斯德所等建立我国首例丙型肝炎病毒感染性DNA克隆, objectType=article, longId=27976, objectId=4fac2e97654, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=4fac2e97654, replyNumber=0, likeNumber=80, createdTime=2014-06-16, rootId=0, userName=aids221, userId=596825099872, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=4fac2e97654, moduleTitle=J Virol：上海巴斯德所等建立我国首例丙型肝炎病毒感染性DNA克隆, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=4fac2e97654)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1660098, encodeId=698e16600984a, content=<a href='/topic/show?id=8d0d28912db' target=_blank style='color:#2F92EE;'>#克隆#</a>, objectTitle=郭艺芳：PCSK9单克隆抗体能否撼动他汀霸主地位？, objectType=article, longId=32846, objectId=95f2328469f, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=95f2328469f, replyNumber=0, likeNumber=82, createdTime=2015-02-09, rootId=0, userName=aids221, userId=596825099872, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=95f2328469f, moduleTitle=郭艺芳：PCSK9单克隆抗体能否撼动他汀霸主地位？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=95f2328469f)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1660092, encodeId=5f841660092ce, content=<a href='/topic/show?id=8d0d28912db' target=_blank style='color:#2F92EE;'>#克隆#</a>, objectTitle=J Virol：我国建立HCV感染性DNA克隆, objectType=article, longId=28861, objectId=806c288613f, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=806c288613f, replyNumber=0, likeNumber=78, createdTime=2014-03-19, rootId=0, userName=aids221, userId=596825099872, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=806c288613f, moduleTitle=J Virol：我国建立HCV感染性DNA克隆, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=806c288613f)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1660094, encodeId=08091660094d4, content=<a href='/topic/show?id=8d0d28912db' target=_blank style='color:#2F92EE;'>#克隆#</a>, objectTitle=Nature：韩国“克隆之父”黄禹锡归来, objectType=article, longId=29517, objectId=ddfe2951e74, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=ddfe2951e74, replyNumber=0, likeNumber=77, createdTime=2014-05-17, rootId=0, userName=aids221, userId=596825099872, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=ddfe2951e74, moduleTitle=Nature：韩国“克隆之父”黄禹锡归来, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=ddfe2951e74)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1660085, encodeId=c5ff1660085c7, content=<a href='/topic/show?id=8d0d28912db' target=_blank style='color:#2F92EE;'>#克隆#</a>, objectTitle=Nature & Science：科学家为克隆胚胎干细胞“突破”辩解, objectType=article, longId=19388, objectId=9ab619388b8, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=9ab619388b8, replyNumber=0, likeNumber=69, createdTime=2014-04-02, rootId=0, userName=aids221, userId=596825099872, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=9ab619388b8, moduleTitle=Nature & Science：科学家为克隆胚胎干细胞“突破”辩解, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=9ab619388b8)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1660087, encodeId=6e38166008ed2, content=<a href='/topic/show?id=8d0d28912db' target=_blank style='color:#2F92EE;'>#克隆#</a>, objectTitle=Nature：单克隆抗体或能有效治疗艾滋病, objectType=article, longId=26192, objectId=aef52619293, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=aef52619293, replyNumber=0, likeNumber=81, createdTime=2014-07-07, rootId=0, userName=aids221, userId=596825099872, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=aef52619293, moduleTitle=Nature：单克隆抗体或能有效治疗艾滋病, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=aef52619293)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

克隆

2020-05-29

aids221 (审核中...)

前往app查看评论内容

#克隆#

Stem Cell Reports：无需克隆的基因编辑技术，可能会改变医学治疗的未来

2015-11-22

aids221 (审核中...)

前往app查看评论内容

#克隆#

Oncotarget：抗β2微球蛋白单克隆抗体能改善硼替佐米的耐药性

2016-02-14

aids221 (审核中...)

前往app查看评论内容

#克隆#

Cancer Cell：新型单克隆抗体药物或可有效克服白血病的耐药性

2016-02-23

aids221 (审核中...)

前往app查看评论内容

#克隆#

J Clin Oncol：人体单克隆抗体新药的试验设计需要改进

2015-11-10

aids221 (审核中...)

前往app查看评论内容

#克隆#

Nature：单克隆抗体Tildrakizumab对牛皮癣可能有效

2016-01-03

aids221 (审核中...)

前往app查看评论内容

#克隆#

Cell Res：生殖细胞克隆新技术

2015-04-28

aids221 (审核中...)

前往app查看评论内容

#克隆#

新一代单克隆抗体类生物制药的特征

2015-04-26

aids221 (审核中...)

前往app查看评论内容

#克隆#

刘梅林：PCSK9单克隆抗体“不负众望”

2014-10-22

aids221 (审核中...)

前往app查看评论内容

#克隆#

“克隆野山羊计划”再次萌动引发热议

2014-09-20

aids221 (审核中...)

前往app查看评论内容

#克隆#

复宏汉霖获得单克隆抗体药物临床批件

2014-11-28

aids221 (审核中...)

前往app查看评论内容

#克隆#

BioTechniques：2014年生物新技术：下一代测序、RCR/克隆、蛋白分析、细胞分析

2014-05-04

hb2008ye (审核中...)

前往app查看评论内容

#克隆#

Sciecne：2013年突破--人体胚胎克隆终获成功咖啡因助力

2014-11-07

aids221 (审核中...)

前往app查看评论内容

#克隆#

“科幻变现实”中国克隆工厂惊人

2014-01-24

aids221 (审核中...)

前往app查看评论内容

#克隆#

Science ：《科学》评年度医学成果克隆技术竟需咖啡帮助

2014-04-05

aids221 (审核中...)

前往app查看评论内容

#克隆#

J Virol：上海巴斯德所等建立我国首例丙型肝炎病毒感染性DNA克隆

2014-06-16

aids221 (审核中...)

前往app查看评论内容

#克隆#

郭艺芳：PCSK9单克隆抗体能否撼动他汀霸主地位？

2015-02-09

aids221 (审核中...)

前往app查看评论内容

#克隆#

J Virol：我国建立HCV感染性DNA克隆

2014-03-19

aids221 (审核中...)

前往app查看评论内容

#克隆#

Nature：韩国“克隆之父”黄禹锡归来

2014-05-17

aids221 (审核中...)

前往app查看评论内容

#克隆#

Nature & Science：科学家为克隆胚胎干细胞“突破”辩解

2014-04-02

aids221 (审核中...)

前往app查看评论内容

#克隆#

Nature：单克隆抗体或能有效治疗艾滋病

2014-07-07

科室
- - 订阅+
  - 更多科室
工具
服务